姜黄素
药理学
餐后
血糖性
2型糖尿病
2型糖尿病
肠道菌群
生物利用度
氧化应激
化学
口服
透明质酸
益生元
菊粉
糖尿病
生物化学
摄入
多酚
肌肽
功能性食品
二甲双胍
抗氧化剂
乳酸
薄荷醇
自愈水凝胶
医学
益生菌
炎症
材料科学
胃酸
碳水化合物代谢
新陈代谢
炎症性肠病
控制释放
作者
Lulu Qi,Fangping Jiang,Linda Chen,Jing Feng,Qinglian Hu,Yuanxiang Jin
摘要
ABSTRACT Type 2 diabetes mellitus (T2DM), a systemic metabolic network disorder, demands multiorgan intervention to restore homeostasis, posing a major global health burden. Concurrent instant glycemic control and long‐term microbiota remodeling represent an urgent scientific challenge. Herein, an inulin (INU) and hyaluronic acid (HA) double network hydrogel (IHGel) is presented to co‐deliver Bifidobacterium longum (BL) and lactoferrin (LF)‑Zn‑epigallocatechin gallate (EGCG) ternary nanoparticles (LZE NPs). The obtained LZE/BL@IHGel as an oral composite platform exhibits acid‑induced protonation to generate pH responsive pore shrinkage in the stomach, which results in protective effects of BL and sustained release of LZE NPs. Furthermore, LZE NPs maintain stable free radical scavenging activity and α ‐glucosidase inhibitory activity via metal–polyphenol coordination assembly and enhance cellular uptake through protein incorporation, thereby alleviating intestinal oxidative stress and controlling postprandial glucose. In a murine model of T2DM, 6 weeks of daily oral LZE/BL@IHGel demonstrated spatiotemporal separation of acute glycemic control and long‑term microbiota modulation by ameliorating glucolipid metabolism and multi‑organ complications, restoring intestinal homeostasis. Collectively, this study offers a versatile oral delivery strategy to bridge immediate glycemic control with long‑term gut remodeling, providing a new avenue for complex metabolic disease intervention.
科研通智能强力驱动
Strongly Powered by AbleSci AI